|
E.V. Biryukova, T.B. Danilova
EFFICACY AND SAFETY OF GLYCAEMIC CONTROL USING DIABETON MR: PREREQUISITE FOR SUCCESSFUL PREVENTION OF CHRONIC COMPLICATIONS OF TYPE 2 DIABETES MELLITUS
|
14-16 |
|
I.A. Kurnikova
METABOLIC SYNDROME IN DIABETIC PATIENTS AND ITS CORRECTION USING THIOCTIC ACID PREPARATIONS
|
20-26 |
|
N.A. Chernikova 1, M.B. Antsiferov 2
ROLE AND PLACE OF HYPOGLYCEMIA IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
|
27-32 |
|
E.A. Ushkalova
NEW CLASS OF ANTIDIABETIC DRUGS - SODIUM- GLUCOSE COTRANSPORTER INHIBITORS
|
33-36 |
|
N.A. Chernikova 1, A.S. Ametov 1, M.B. Antsiferov 2
BASAL INSULIN THERAPY: EXPERIENCE IN CLINICAL PRACTICE
|
37-41 |
|
M.B. Antsiferov 1; V.S. Pronin 2; T.M. Alekseeva 1, L.G. Dorofeeva 1
EXPERIENCE OF MAINTENANCE OF MOSCOW REGISTER OF PATIENTS WITH ACROMEGALY: POTENTIALS FOR THE SOLUTION OF VARIOUS THERAPEUTIC PROBLEMS
|
42-47 |
|
M.B. Antsiferov
LONG-TERM SAFETY AND EFFICACY OF INSULIN ASPART IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
|
48-51 |
|
M.E. Statsenko, M.V. Derevyanchenko
FEATURES OF MANAGEMENT OF HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS: A VIEW OF CARDIOLOGIST
|
52-57 |
|
E.V. Biryukova, T.B. Danilova
PHARMACOTHERAPY OF DIABETIC NEUROPATHY: WHAT ELSE EXCEPT GLYCEMIC CONTROL?
|
58-63 |
|
A.S. Ametov
ADVANTAGES OF THE NEW FIXED COMBINATION OF SAXAGLIPTIN AND TIME-RELEASE METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
|
64-70 |
|
A.S. Ametov, E.A. Tertychnaya
MANAGEMENT OF LIPOTOXICITY IN THE DEBUT OF TYPE 2 DIABETES MELLITUS
|
72-77 |
|
O.A. Shavlovskaya, MD
FEATURES OF STROKE THERAPY IN DIABETIC PATIENTS
|
78-83 |
|
N.A. Strebkova
MAIN PRINCIPLES OF TREATMENT OF DIABETES INSIPIDUS IN CHILDREN
|
84-87 |
|
L.N. Gorobets
GENERAL ISSUES OF DIAGNOSIS AND PREVENTION OF NEUROENDOCRINE DYSFUNCTIONS IN PSYCHIATRIC PATIENTS
|
88-91 |
|
Yu.E. Poteshkin
THE CASE OF PSEUDOHYPOPARATHYREOSIS IN 33 YEAR-OLD MAN
|
92-95 |
Русский
